Lipemia retinalis in acquired immunodeficiency syndrome treated with protease inhibitors

Archives of Ophthalmology

Volumn 118, Issue 3, 2000, Pages 425-426

  Eng, Kenneth T ^b   Liu, Eugene S ^b   Silverman, Michael S ^b   Berger, Alan R ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CHOLESTEROL; COTRIMOXAZOLE; DELAVIRDINE; FOSCARNET SODIUM; INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; RIFABUTIN; RITONAVIR; SAQUINAVIR; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; EYE DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RETINA DETACHMENT; RETINITIS; VIRUS INFECTION; VITRECTOMY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CHOLESTEROL; DELAVIRDINE; DRUG THERAPY, COMBINATION; HIV PROTEASE INHIBITORS; HUMANS; HYPERLIPIDEMIAS; MALE; RETINAL DISEASES; RETINAL VESSELS; RITONAVIR; SAQUINAVIR; TRIGLYCERIDES; VIRAL LOAD; ZALCITABINE;

EID: 0034065772     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Vinger PF, Sachs BA. Ocular manifestations of hyperlipoproteinemia. Am J Ophthalmol. 1970; 70:563-573.
2. Henkes HE, Houtsmuller AJ, Bos PJ, Crone RA. Fundus changes in primary hyperlipidemia. Ophthalmologica. 1976;173:190-195.
3. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidemia, and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998;12(suppl):F51-F58.
4. Carr A, Samaras K, Chisholm DJ, Cooper DA. Pathogenesis of HIV-1 protease inhibitor-associaled peripheral lipodystrophy, hyperlipidemia, and insulin resistance. Lancet. 1998;351: 1881-1883.